Exploring how certain proteins interact with modified histones to regulate gene expression
PROBING ALLOSTERY IN METHYL-LYSINE READER DOMAINS
This study is exploring how certain proteins help control gene activity in our cells, which could lead to new treatments for diseases by using special molecules to better understand these processes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11002715 on NIH RePORTER |
What this research studies
This research investigates the role of methyl-lysine reader domains in chromatin regulation, focusing on how these proteins can influence gene expression through post-translational modifications of histones. By utilizing small molecules as chemical probes, the study aims to understand the mechanisms of chromatin accessibility and its implications for therapeutic interventions. The approach combines biophysical techniques and chemical biology to develop probes that can effectively modulate chromatin states, potentially leading to new drug discovery opportunities. Patients may benefit from insights gained into the regulation of gene expression that could inform future treatments for various diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions related to chromatin regulation and gene expression abnormalities.
Not a fit: Patients with conditions unrelated to chromatin regulation or those not affected by gene expression changes may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases linked to gene expression dysregulation.
How similar studies have performed: Previous research has shown promise in using chemical probes to explore chromatin biology, indicating potential for success in this novel approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Frye, Stephen Vernon — Univ of North Carolina Chapel Hill
- Study coordinator: Frye, Stephen Vernon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.